McKesson (FRA:MCK) Long-Term Debt: €4,549 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:MCK McKesson Corp FRA:MCK
84 GF Score
Price €689.20
GF Value €675.90
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is McKesson Long-Term Debt?

McKesson FRA:MCK -1.20% 84 Long-Term Debt is €4,549 Mil as of Mar. 2026. GuruFocus rates FRA:MCK with a GF Score™ of 84/100 and a GF Value™ of €675.90 (Fairly Valued). The stock has 2 warning signs investors should review.

McKesson's Long-Term Debt for the quarter that ended in Mar. 2026 was €4,549 Mil.

McKesson's quarterly Long-Term Debt declined from Sep. 2025 (€5,121 Mil) to Dec. 2025 (€4,633 Mil) and declined from Dec. 2025 (€4,633 Mil) to Mar. 2026 (€4,549 Mil).

McKesson's annual Long-Term Debt declined from Mar. 2024 (€5,133 Mil) to Mar. 2025 (€4,128 Mil) but then increased from Mar. 2025 (€4,128 Mil) to Mar. 2026 (€4,549 Mil).

McKesson  (FRA:MCK) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

McKesson Long-Term Debt Related Terms

McKesson Long-Term Debt Historical Data

* Premium members only.

The historical data trend for McKesson's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

McKesson Long-Term Debt Chart

McKesson Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,612.64 4,320.68 5,132.68 4,128.28 4,549.04

McKesson Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,128.28 5,659.78 5,121.37 4,632.95 4,549.04
FRA:MCK
84GF Score
McKesson Corp FRA:MCK
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of €4,549 Mil mean?
McKesson (FRA:MCK) has a Long-Term Debt of €4,549 Mil as of Mar. 2026.
Is McKesson's Long-Term Debt too high?
McKesson's current Long-Term Debt is €4,549 Mil. Overall, McKesson has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does McKesson's Long-Term Debt compare to CAH and COR?
McKesson's Long-Term Debt of €4,549 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Distribution company?
A good Long-Term Debt depends on the Medical Distribution industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. McKesson's current Long-Term Debt is €4,549 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is McKesson stock overvalued right now?
Based on GuruFocus' analysis, McKesson (FRA:MCK) is currently considered Fairly Valued. The stock's GF Value™ is €675.90, compared to a current price of €689.20 — trading 2% above its estimated fair value. The current Long-Term Debt is €4,549 Mil. McKesson's overall GF Score™ is 84/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For McKesson (FRA:MCK), the current Long-Term Debt is €4,549 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is McKesson (FRA:MCK) Overvalued in 2026?

Based on GuruFocus' analysis, McKesson stock appears to be overvalued. The current stock price of €689.20 is trading 2% above its estimated GF Value™ of €675.90. GuruFocus considers McKesson to be Fairly Valued.

Key valuation signals for FRA:MCK:

  • Long-Term Debt: €4,549 Mil
  • GF Value™: €675.90 vs. price of €689.20 (2% above fair value)
  • GF Score™: 84/100 with 2 warning signs

No single metric tells the full story. See the FRA:MCK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

McKesson Business Description

Address 6555 State Highway 161, Irving, TX, USA, 75039
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
84GF Score

Get the complete analysis for FRA:MCK

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€689.20
Price
€675.90
GF Value